Arax Advisory Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.68M Buy
14,709
+13,951
+1,841% +$1.64M 0.01% 1073
2026
Q2
$80.8K Buy
758
+606
+399% +$73.4K ﹤0.01% 2885
2026
Q1
$24.9K Sell
152
-215
-59% -$33.1K ﹤0.01% 1998
2025
Q4
$63.9K Sell
367
-422
-53% -$77K ﹤0.01% 1496
2025
Q3
$114K Buy
789
+683
+644% +$83.7K ﹤0.01% 1492
2025
Q2
$12K Buy
106
+80
+308% +$6.12K ﹤0.01% 1886
2025
Q1
$1.98K Buy
26
+13
+100% +$994 ﹤0.01% 2072
2024
Q4
$898 Sell
13
-14
-52% -$1.01K ﹤0.01% 2199
2024
Q3
$1.97K Buy
27
+9
+50% +$664 ﹤0.01% 2071
2024
Q2
$1.21K Sell
18
-7
-28% -$271 ﹤0.01% 2115
2024
Q1
$679 Hold
25
– – ﹤0.01% 1208
2023
Q4
$775 Hold
25
– – ﹤0.01% 1167
2023
Q3
$631 Hold
25
– – ﹤0.01% 1213
2023
Q2
$528 Buy
25
+1
+4% +$19 ﹤0.01% 1205
2023
Q1
$409 Hold
24
– – ﹤0.01% 1214
2022
Q4
$480 Buy
+24
New +$464 ﹤0.01% 1186

Other funds holding INSM

Arax Advisory Partners's INSM Position: Q3 2026 in Review

Arax Advisory Partners increased its Insmed (INSM) stake by 1,841% in Q3 2026, buying an estimated $1.64M and bringing the position to 14,709 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #1073.

Arax Advisory Partners first reported a position in INSM in Q4 2022 and has held it in 16 quarters since. 706 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Arax Advisory Partners held 14,709 shares of Insmed worth $1.68M as of Q3 2026.
  • Arax Advisory Partners bought 13,951 Insmed shares in Q3 2026, an estimated $1.64M.
  • Insmed made up 0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #1073 holding.
  • Arax Advisory Partners first reported a position in Insmed in Q4 2022 and has held it in 16 quarters since.
  • 706 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.